FDA Issues Its Highest-Risk Recall for Epidural Kits Over Contaminated Saline Ampules
The same contaminated flush ampules already tied to an IV saline recall have now triggered a Class I action on epidural kits used in regional anesthesia — the FDA's most serious safety category.
Meridians Life Desk
Published 11 September 2026 · Updated 11 September 2026 · 4 min read
HealthThe short answer
- The FDA issued a Class I correction notice on September 10, 2026, for Medical Action Industries, covering three epidural kit models across 16 lot numbers.
- The kits contain 10 mL sodium chloride flush ampules made by Huons Co. and recalled by Spectra Medical Devices over possible sterility failure.
- The FDA's Class I label — its most serious — cites risk of infection, spinal infection, organ failure, paralysis or death; no serious injuries had been reported as of July 23, 2026.
- Hospitals are told to quarantine and discard the flush ampules but may keep using the rest of each kit; several other device makers have issued separate corrections tracing to the same ampule supplier since July.
A contamination problem that first surfaced in IV saline bags has now reached a different corner of the hospital supply closet. The FDA has classified a correction from Medical Action Industries as a Class I recall — its highest-risk category — for epidural kits used in regional anesthesia.
What's being recalled
- Three Medical Action Industries epidural kit models: 82465, 59553, and 83945B
- 16 specific lot numbers, per the FDA's September 10, 2026 correction notice
- The kits contain 10 mL sodium chloride 0.9% USP flush ampules made by Huons Co., Ltd., separately recalled by Spectra Medical Devices
Why it's Class I
The FDA says the ampules may contain viable microorganisms, endotoxins, or foreign matter, which in an epidural context could cause infection, inflammation, blood clots, organ failure, spinal infection, paralysis, or death. Class I is reserved for situations where using the product could cause serious injury or death. As of July 23, 2026, the FDA notice states no serious injuries had been reported. Hospitals are instructed to quarantine and discard the affected flush ampules; the rest of each kit can still be used.
A widening supply-chain problem
This is not an isolated event. Because the same recalled ampules were packaged into different kits by multiple manufacturers, separate corrections have gone out from other device makers since July 2026 as each one traces the same root cause through its own product lines and notifies the FDA individually.
Sources
Every factual claim above is traceable to these documents. Check them — that is why they are here.
- Epidural kit correction — Medical Action IndustriesU.S. Food and Drug Administration
- FDA convenience-kit recalls widen across manufacturersMedical Daily
About this byline
Meridians Life Desk is an editorial desk at Meridians, not an individual. A desk byline means the article was produced and fact-checked to that desk's published standards. Read our editorial standards and corrections policy.
Sponsored
Paid placement · not editorial
Nationwide Recall of At-Home IV Wellness Drips Over Contamination Risk
4 min read · 14 September 2026
FDA Approves the First Drug for Alexander Disease, a Rare Brain Disorder With No Prior Treatment
4 min read · 8 September 2026
FDA Approves First-of-Its-Kind Drug for Rare Blood Disorder Polycythemia Vera
4 min read · 2 September 2026
The Meridians Brief
One considered email a week
What changed, what it costs you, and what to do about it — from the Meridians desks. No sponsored picks disguised as recommendations.
Sign-up opens with our launch issue. Nothing is sent or stored yet.